Collectively, these observations suggested that Linc01056 knockdown resulted in a metabolic switch from glycolysis towards FAO in sorafenib-treated HCC cells that increased the efficiency of energy production. The gene discussed is LINC01056; the disease is hepatocellular carcinoma.